Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.
about
Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic reviewChronic fatigue syndromeFatigue in rheumatic diseasesTraditional chinese medicine for chronic fatigue syndrome.Interventions for the treatment and management of chronic fatigue syndrome/myalgic encephalomyelitisAssociation between chronic fatigue syndrome and the corticosteroid-binding globulin gene ALA SER224 polymorphism.New agents for the treatment of cancer-related fatigue.High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome.The debate: myalgic encephalomyelitis and chronic fatigue syndrome.Infection and vaccination in chronic fatigue syndrome: myth or reality?The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.Stress hormones: how do they measure up?Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome?Day-to-day dynamics of experience--cortisol associations in a population-based sample of older adults.Chronic fatigue syndrome: an endocrine disease off limits for endocrinologists?Management of cancer-related fatigue.Glucocorticoid-induced inhibition of memory retrieval: implications for posttraumatic stress disorder.Pediatric Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.The effects of galantamine hydrobromide treatment on dehydroepiandrosterone sulfate and cortisol levels in patients with chronic fatigue syndrome.Biological mechanisms of chronic fatigue.Clinical Practice: Chronic fatigue syndrome.How well is the clinical importance of study results reported? An assessment of randomized controlled trials.The 1microg short Synacthen test in chronic fatigue syndrome.Biological outcome measurements for behavioral interventions in multiple sclerosis.HPA axis reactivity in chronic pelvic pain: association with depression.Conceptualising the neurobiology of fatigue.Plasma leptin in chronic fatigue syndrome and a placebo-controlled study of the effects of low-dose hydrocortisone on leptin secretion.Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.Bupropion sustained release treatment reduces fatigue in cancer patients.Disturbed adrenal function in adolescents with chronic fatigue syndrome.Fatigue in cystic fibrosis: a novel prospective study investigating subjective and objective factors associated with fatigue.Glucocorticoids and glucocorticoid receptors: mediators of fatigue?Chronic unexplained fatigue.Chronic fatigue syndrome in the psychiatric practice.Atypical depression spectrum disorder - neurobiology and treatment.Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: a case series.Chronic fatigue syndrome
P2860
Q22241583-DBBBF798-E085-4AD0-AE4E-5CAA77C80548Q24524596-5D9CE75D-0B7B-4DAF-93DA-4DB956E5B155Q28079588-20B52971-B1BC-49FB-B9D6-7E4073BF8AF5Q30483511-98457156-C02B-4F25-A1EF-E7E7FCC0A34FQ34165444-A664C5AC-A592-4A4F-A3A5-94525632CCDCQ34369519-701E37F1-6D46-437C-BA81-AFD5852ED37BQ34400149-58A6808B-C8F6-4A56-9CAF-F49293C6A07DQ34404797-8A2D7228-27FB-447F-9CC5-13ECE80B85B8Q34546727-81CA9DE8-D190-485D-AFE3-4D957BAA1F12Q34609090-F555F204-6863-49F6-9301-322E24B827B6Q34622270-6FF784F0-5F56-4F5B-A6E0-383ED04DBCB2Q34680436-425736E4-1826-4BCE-9EF9-690D7AF83A15Q34984503-85216C3D-FAC8-492D-A732-056FC220A71CQ34992592-94F73E42-B1F1-4E17-B222-033919A64498Q35130890-193209A9-1AAB-44A2-BFA4-341EEC5E0E71Q35592461-5BFA6766-18CB-4BF9-828A-8049DBB47CEAQ36156911-56E6C021-B27C-41DD-B1C1-403AC1EE0B34Q36557690-C44AAC38-3531-4397-BD7B-5A4CF7ED98F4Q37377758-5730B630-D79C-464F-9DA1-E62A9E4E5EB4Q37484198-63C8FB1D-85A0-4A28-8CE8-170D6FD56D0CQ37834153-E3A24AC3-C4B3-458D-83A8-561821C38EFAQ38113720-122600C4-5099-4E36-AAE6-512406C78427Q39434130-558B58AC-C292-4544-B972-915273307644Q40786489-614E0A99-81FA-4462-A9D3-0D5D9CB2EBC3Q42789516-E7CF5828-6243-4DE5-AA8D-86AB1FCC8396Q43239568-A2440F30-EEA0-49AB-9C15-9FCEB4CBC1BCQ43547918-FDAF2F5F-3704-4E86-B924-BCD04BF44600Q43674526-0DCBA3DD-A3EA-4996-B9CB-9E78230B726FQ44348182-53837158-E41C-4006-975E-712F062F8E0BQ44831233-6AAF2699-9182-4513-849F-FA17226050A2Q46424767-F6C47549-E9FD-46DF-A9FF-FE982FEC491CQ48213955-FB679450-0178-40F0-9641-91FDD300A747Q48609845-ECB0E505-147C-441A-883E-BE0F7785915FQ48737826-65CF11DD-9EBC-493C-8046-BE783608E167Q49046423-F935BFBB-19C4-43E6-84ED-CAC9E73843C2Q52950284-E2615EA4-2C59-4F71-B0F1-469C00065CFDQ54036035-6BE44C3C-0A97-4032-B180-9167A8673B9AQ57356415-BE67F558-4498-4C7B-8E5D-AD0D54973D18
P2860
Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.
@ast
Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.
@en
Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.
@nl
type
label
Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.
@ast
Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.
@en
Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.
@nl
prefLabel
Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.
@ast
Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.
@en
Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.
@nl
P2093
P1433
P1476
Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.
@en
P2093
P304
P356
10.1016/S0140-6736(98)04074-4
P407
P577
1999-02-01T00:00:00Z